The US Food and Drug Administration (FDA) has approved an amphetamine extended-release orally disintegrating tablet (Adzenys XR-ODT) for the treatment of attention ...

Please provide your email address to receive an email when new articles are posted on . The FDA recently approved Adzenys XR-ODT for the treatment of attention ...

Granules India Ltd on Thursday said its arm Granules Pharmaceuticals, Inc has received tentative approval from the US health ...

Neos Therapeutics Inc. recently announced the FDA approved Cotempla XR-ODT, an extended-release orally disintegrating tablet, for the treatment of ADHD in children aged 6 to 17 years. “Cotempla XR-ODT ...

Granules India arm gets USFDA tentative nod for generic ADHD tablets with 180-day exclusivity eligibility, expanding its ...

Objective: To compare the flavour and taste preferences of two acid-inhibitory therapies in children. Subjects and Setting: 104 (52 male and 52 female) healthy children aged 6-11 years participated in ...

(RTTNews) - Endo USA, Inc., affiliated to generics and specialty branded pharmaceutical company Endo, Inc., is recalling one lot of Par Pharmaceutical, Inc.'s Clonazepam Orally Disintegrating Tablets, ...

MNMD is developing its lead pipeline candidate MM120, an orally disintegrating tablet (ODT) and a pharmaceutically optimized ...

Princeton, New Jersey; October 18, 2010 - Sandoz today announced the introduction of lansoprazole delayed-release orally disintegrating tablets (ODT), an authorized generic equivalent of Prevacid® ...

Omeprazole ODT utilizes MelTech technology that allows the tablet to dissolve in the mouth without water. Perrigo announced the launch of store brand Omeprazole Delayed Release Orally Disintegrating ...

Dublin, Oct. 09, 2025 (GLOBE NEWSWIRE) -- The "Orally Disintegrating Tablet Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By ...